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We appreciate the attention that Weller et al. have given to our report and findings. Weller et 
al. used an in vitro system based on Huh-7.5 cells silenced for endogenous apolipoprotein E 
(apoE) protein expression to investigate if genetic variants of the APOE gene (ϵ2, ϵ3, and 
ϵ4), when ectopically expressed, influence the production of intracellular hepatitis E virus 
(HEV) RNA and the expression of HEV open reading frame 2 (ORF2) protein after the cells 
were transfected with an HEV genotype 3 replicon. Finding that HEV RNA and ORF2 
protein production were not affected regardless of which isoforms were expressed, they 
concluded that APOE polymorphisms do not affect HEV RNA replication and virus 
production.
HEV RNA quantification was applied by Weller et al. as an index of viral replication, and 
ORF2 protein quantification was used as a marker of the extent of viral particle assembly. 
However, HEV RNA measurement shows replication of the viral genome, not productive 
viral replication. Furthermore, measurement of the ORF2 protein, per se, is inadequate to 
indicate virion assembly; and other means of verifying if assembly has taken place are 
needed.(1)
We also note that although the data depicted in Fig. 1C,D show a trend in the reduction in 
production levels of HEV RNA and ORF2, respectively, when HuH-7.5 cells were incubated 
in the presence of ribavirin, no formal statistics were applied to analyze the trend. The 
ranges for the ribavirin-associated data points were wide. In addition, genotypes 1 and 3 
were reported by HEV surveillance as principal infecting genotypes in the United States(2); 
Weller et al. only used genotype 3 in their experiments.
Weller et al. also concluded that their data do not support the findings of our study,(3) 
suggesting that APOE ϵ3 and APOE ϵ4 were associated with protection against HEV 
infection in non-Hispanic blacks but not in non-Hispanic whites or Mexican Americans. 
What we conducted was a population-based genetic epidemiologic association study 
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following up on previously reported epidemiologic data showing the anti-HEV seropositivity 
rate among non-Hispanic blacks to be lower than that among the other two racial/ethnic 
groups.(4) We identified the host genetic factor associated with the lower seropositivity to be 
APOE or genes that are in linkage disequilibrium with APOE.
Assuming that APOE is a gene that confers protection against HEV infection, we proffered 
various mechanisms by which the apoE protein can exert such protection: (1) HEV using the 
same hepatocyte entry mediators as those of apoE, (2) the incorporation of apoE in the HEV 
envelope, and (3) apoE modulating the immune response against HEV. The role of apoE as 
having the capability to affect HEV replication was not considered, as Weller et al. had.
REFERENCES
1). Cao D, Meng XJ. Molecular biology and replication of hepatitis E virus. Emerg Microbes Infect 
2012;1:e17. [PubMed: 26038426] 
2). Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, et al. 
Laboratory-based surveillance for hepatitis E virus infection, United States, 2005–2012. Emerg 
Infect Dis 2013;19:218–222; quiz 353. [PubMed: 23347695] 
3). Zhang L, Yesupriya A, Chang MH, Teshale E, Teo CG. Apolipo-protein E and protection against 
hepatitis E viral infection in American non-Hispanic blacks. Hepatology 2015;62:1346–1352. 
[PubMed: 26096528] 
4). Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of 
hepatitis E virus in the United States: results from the Third National Health and Nutrition 
Examination Survey, 1988–1994. J Infect Dis 2009;200:48–56. [PubMed: 19473098] 
Teo et al. Page 2
Hepatology. Author manuscript; available in PMC 2019 August 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
